US Patent 11365239 Anti-SARS-COV-2 antibodies and uses thereof
All edits
Edits on 28 Apr, 2023
Golden AI
Infobox
Edits on 6 Apr, 2023
Golden AI
Infobox
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
113652390
Date of Patent
June 21, 2022
0Patent Application Number
169533040
Date Filed
November 19, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
113652390
Date of Patent
June 21, 2022
0Patent Application Number
169533040
Date Filed
November 19, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 22 Jun, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+365 characters)
US Patent 11365239 Anti-SARS-COV-2 antibodies and uses thereof
Article
Provided herein are modified anti-SARS-COV-2 antibodies or antigen binding fragments thereof having extended half life and optimized immune activities. Disclosed herein is also directed to pharmaceutical compositions comprising the same and a method for treating or preventing a disease in human patients that is caused by or related to the infection of SARS-COV-2.
Infobox
Is a
Patent jurisdiction
Patent number
11365239
Date of patent
June 21, 2022
Patent application number
16953304
Date Filed
November 19, 2020
Patent citations
Patent primary examiner
CPC Code
Find more entities like US Patent 11365239 Anti-SARS-COV-2 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
